~~<i id='B080C4A2A3'><strike id='B080C4A2A3'><tt id='B080C4A2A3'><pre id='B080C4A2A3'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：focus 2025-09-06 03:15:13 - browse：71

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Health tech startups drop sharply from 2021 highs

hotspot

Wikipedia

explore

entertainment

explore

Wikipedia

Sen.RandPaul(R-Ky.)WinMcNamee/GettyImagesWASHINGTON—ASenatepanelWednesdaypassedabillaimedatpreventin

WSS

Why do women spend more than men on medical expenses?

UnitedHealth quietly bought dozens of outpatient centers

Shingles, which affected Dianne Feinstein, is on the rise

Cigna to pay $172 million to settle Medicare Advantage fraud probe

WHO recommends dropping component of many flu vaccines

Cigna to pay $172 million to settle Medicare Advantage fraud probe

focus

Wikipedia

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Novo Nordisk gets FDA approval to tout heart benefits of Wegovy

The high cost of giving birth even with insurance

Change Healthcare cyberattack prompts Medicare loan program

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Data show record exodus of life scientists from academia

Tori Bowie and the unacceptable rates of Black maternal death

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Former medical device CEO who sold dummy, plastic parts convicted of fraud

Wikipedia

Menendez indictment could see pharma lose a key ally

First medicine developed to treat MASH expected to be approved soon

RSV shot was 90% effective at preventing hospitalizations in kids

Senator probes 340B programs at Cleveland Clinic, Bon Secours

FDA advisers vote against ALS treatment from BrainStorm

Sen. Paul opposes bill to ban Chinese biotechs

explore

entertainment

explore

Wikipedia